Ketone Pharmacokinetic Study in HFrEF

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 2, 2023

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DIETARY_SUPPLEMENT

DeltaG (250 mg/kg)

250 mg/kg of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

DIETARY_SUPPLEMENT

DeltaG (500 mg/kg)

500 mg/kg of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Heart Association

OTHER

lead

Duke University

OTHER

NCT05757193 - Ketone Pharmacokinetic Study in HFrEF | Biotech Hunter | Biotech Hunter